Live webcasts of the fireside chat will be available in the Investors section of Replimune’s website at www.replimune.com. A replay will be available for 30 days following the conference. Replimune ...
What if every person you meet, including those you’ve yet to cross paths with, is quietly tethered to you by a single thread you can't even see? That's the premise of the invisible string theory. The ...
Shares of Replimune Group, Inc. (REPL) have gained 0.7% over the past four weeks to close the last trading session at $7.76, but there could still be a solid upside left in the stock if short-term ...
Biological systems are notoriously tough to model, especially when it comes to figuring out the axons, neurons, blood vessels, and other structural components of gray matter, or the tissue that makes ...
Years ago, an audacious Fields medalist outlined a sweeping program that, he claimed, could be used to resolve a major problem in algebraic geometry. Other mathematicians had their doubts. Now he says ...
Marika Taylor currently receives funding from EPSRC, STFC, UK government deparments and the European Horizon programme. In 1980, Stephen Hawking gave his first lecture as Lucasian Professor at the ...
In 1980, Stephen Hawking gave his first lecture as Lucasian Professor at the University of Cambridge. The lecture was called "Is the end in sight for theoretical physics?" Forty-five years later, ...
The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $10.84 / share. This is an increase of 48.75% from the prior estimate of $7.29 dated September 27, 2025. The ...
The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results